Early Persian practitioners were aware of the systemic effect of nasally applied medicaments. Having the remained knowledge of other medical systems and their own experiences, they formulated many types of nasal dosage forms involving powder, solution and also gaseous preparations. The target site was either in the nasal area or even in the upper regions. But most of them were related to CNS disorders (
19). Consistent with this belief, eleven types of nasal approaches encompassing powder, liquid and gaseous forms have been recorded in related manuscripts. Among them, powdered forms were subdivided to nasal insufflation (Nofookh) and errhine or sternutator medicine (Otoos). On the other hand, solutions or liquids contained nasal drop (
Qotoor) and nasal snuffing drop (
Saoot) as well as liquid snuff formulation (
Noshoogh). Finally the last reported nasal dosage forms found as gaseous preparations were as fumigations (
Bakhoor), medicinal vapor bathes or boiled aqueous extracts (
Enkebab) and inhalation forms (
Lakhlakheh) as well as aroma agents (
Ghalieh). Interestingly, smelling a herb for a period of time was also considered as a pharmacological approach (
Shomoom) (
15-
17).
The form of fumigation (
Bakhoor) was prepared by simply burning the herb and introducing the resultant smoke to the nasal fossa. Like in contemporary medicine, vapor bath (
Enkebab) was the inhalation of vapors resulted from the decoction of a certain medicinal herb in a liquid base. In the form of aroma agent (Ghalieh) the desired parts of the herb were to be dispersed in vinegar of rosewater and smelled subsequently(
17). The use of cooked musk in this form was very popular in the management of fainted patient (
15). Inhalation (
Lakhlakheh) was mentioned as the smelling of odor rising from either liquid or solid medicine kept in a bottle. The preparation was to be inhaled nasally during a day (
16). These forms may be adapted to what is accepted as aromatherapy in current terminology (
24), the approach which is now recommended for many medical interventions (
25). Nasal drops (
Qotoor) were applied as solutions similar to those of today’s medicine. For the preparation of
Qotoor medicaments should have been thoroughly dispersed in water, milk, vinegar or other specific plant juice for the reduction of particle size. Nasal drops were often applied for the complications occurred in the nasal cavity. On the other hand, nasal snuffing drops (
Saoot) were mentioned as watery or oily drops to be snuffed as entering the nasal fossa. Apparently this form was the most often applicable nasal liquid dosage forms in TPM. Watery or oily base were the same as for
Qotoor (
18). The recent dosage form was widely applied for diseases such as headaches, paralysis, apoplexy, stroke and other CNS disorders (
19). Finally, liquid snuff formulation (
Noshoogh) was defined as an applied liquid nasal dosage form in which a watery preparation of a medicine is sucked into the nose by inhaling (
17). This form was similar to the
Saoot form unless the container was different (
14).
Tables 1 and
2 present some examples of simple and compound medicines used as nasal dosage forms respectively.
As powdered nasal dosage forms, insufflation or snorting agent (Nofookh) was reported as the practice of inhaling a solid substance and errhine or sternutator agent (Otoos) was introduced as a medicament in form of a fine powder with the potency of sneezing promotion (
14). Persian scholars believed in the reduction of particle size of agents for nasal insufflation. Similarly, current investigations revealed the fact that particles around 100 microns in size possess useful insufflation properties for nasal administration (
26). This from is also known as a way of substance abuse (
27,
28). Application of errhine form was for diseases such as rhinitis, common cold, headaches, seizure, facial paralysis and other related ailments related to the nervous system (
19). According to other traditional systems of medicine, errhine therapy was a popular approach to manage some CNS disorders (
29,
30). In current pharmaceutical knowledge, the concept of nasal delivery has gained in interest. As a novel route for administration, nasal delivery is a potentially alternative way for systemic bioavailability in parenteral restricted applications (
31). Desirable penetration, rapid onset of action, absence of hepatic first pass effect and protecting from gastric break down as well as promising results for CNS drug delivery via the olfactory region are some attributed advantages of this application route (
32-
34). Moreover, drugs which have high molecular weight or the ones which are potentially biosensitive such as peptides, vaccines, proteins and so on are good candidates to be delivered through nasal route (
35).